Introduction: Hirschsprung's disease is a congenital anomaly characterised by a rarefaction or absence of ganglion cells associated with schwannian hyperplasia or hypertrophy involving the colon or a segment of the colon. Its diagnosis is based on clinical, radiological and histological evidence. Haematoxylin-eosin examination is used in cases of suspected Hirschsprung's disease. However, in some situations it is insufficient to confirm or refute the diagnosis. Immunohistochemical and histo-enzymatic techniques can be used to demonstrate aganglionosis. The aim of our study is to evaluate the interest of calretinin in the diagnosis of Hirschsprung's disease in Dakar. Materials and methods: This was a retrospective and descriptive study from 1 January 2018 to 31 August 2019. It was conducted at the pathology laboratory of Idrissa Pouye General Hospital where 51 paraffin blocks from suspected Hirschsprung's Disease cases were included. All blocks were immunohistochemically studied with anti-calretinin antibody. The diagnosis of Hirschsprung's disease on standard histological examination was based on the absence of lymph node cells in the submucosal and myenteric plexuses. Calretinin immunoreactivity was shown by nuclear and cytoplasmic labelling of ganglion cells and nerve nets. In Hirschsprung's disease, there is an absence of labelling of the nerve plexuses. Results: The majority of patients (73.5%) were aged 2 years or older with a mean age of 3.4 years. The sex ratio was 2. Biopsies constituted 56.86% of the specimens and surgical specimens 43.14%. Concordance between haematoxylin-eosin examination and calretinin immunohistochemistry was observed in 47 cases (92.15%) and discordance in 4 cases (7.15%). The sensitivity of calretinin was 93.75% and the specificity 89.47%. The kappa index was 0.92. The recto-sigmoid form was the most frequent topographic form observed in 83.3% of patients. Conclusion: Morphological examination with haematoxylin-eosin remains a good diagnostic method for Hirschsprung's disease. Calretinin immunohistochemistry is necessary in equivocal cases, in neonates and infants and in case of superficial biopsies.
| Published in | American Journal of Pediatrics (Volume 7, Issue 3) |
| DOI | 10.11648/j.ajp.20210703.27 |
| Page(s) | 178-181 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Hirschsprung, Lymph Node Cells, Calretinin, Dakar
| [1] | Granstrom AL, Svenningsson A, Hagel E. Maternal risk factors and perinatal characteristics for Hirschsprung’s disease. Pediatrics 2016; 138: 1508-1512. |
| [2] | Gonzalo DH, Plesec T. Hirschsprung Disease and Use of Calretinin in Inadequate Rectal Suction Biopsies. Arch Pathol Lab Med 2013; 137: 1099–1102. |
| [3] | Meinds RJ, Kuiper GA, Parry K et al. Infant’s age influences the accuracy of rectal suction biopsies for diagnosing of Hirschsprung’s disease. Clin Gastroenterol Hepatol 2015; 13: 1801-1807. |
| [4] | Singh SJ, Croaker GD, Manglick P et al. Hirschsprung’s disease: the Australian Paediatric Surveillance Unit’s experience. Pediatr Surg Int 2003; 19: 247–250. |
| [5] | Fernandez RM, Bleda M, Luzon-Toro B et al. Pathways systematically associated to Hirschsprung’s disease. Orphanet J Rare Dis 2013; 8: 187. |
| [6] | Kapur RP, Reed RC, Finn LS, Patterson K et al. Calretinin immunohistochemistry versus acetylcholinesterase histochemistry in the evaluation of suction rectal biopsies for Hirschsprung disease. Pediatr Dev Pathol 2009; 12: 6-15. |
| [7] | Hiradfar M, Sharifi N, Khajedaluee M, Zabolinejad N et al. Calretinin immunohistochemistry: an aid in the diagnosis of Hirschsprung’s disease. |
| [8] | Hackam DJ, Reblock KK, Redlinger RE, Barksdale Jr EM. Diagnosis and outcome of Hirschsprüng’s disease: does age really matter? Pediatr Surg Int 2004; 20 (5): 319-22. |
| [9] | Musa AZ, Quasim BJ, Ghazi HF, Al Chaikhli AWAK. Diagnostic roles of calretinin in hirschprung disease: a comparaison to neuron specific enolase. Saudi J Gastrienterol 2017; 23 (1): 60-66. |
| [10] | Ongeti K, Saidi H, Ogeng’o J, Tharao M. Experience with hirschsprung’s Disease at a Tertiary Hospital in Kenya. The Annals of African Surgery 2009, 4: 8–12. |
| [11] | Bradnock TJ, Knight M, Kenny S, Nair M, Walker GM. Hirschsprung’s disease in the UK and Ireland: incidence and anomalies. Arch Dis Child 2017; 102: 722-727. |
| [12] | Galazka P, Szylberg L, Bodnar M, Styczynski J et al. Diagnostic Algorithm in Hirschsprung’s Disease: Focus on Immunohistochemistry Markers. In vivo 2020; 34: 1355-1359. |
| [13] | Kannaiyan L, Madabhushi S, Malleboyina R, Are NK, Reddy KR, Rao B. Calretinin immunohistochemistry: A new cost-effective and easy method for diagnosis of Hirschsprung's disease. J Indian Assoc Pediatr Surg 2013; 18 (2): 66-68. |
| [14] | Elhalaby ER, Oreiby RM, Hasby AE, Sallam FA. Evaluation of the role of Immunohistochemical markers in the diagnosis of Hirschsprung's Disease. Journal of American Science 2016; 12 (8); 41-50. |
| [15] | Muise ED, Haven RACN. Rectal biopsy for Hirschsprung's disease: A review of techniques, pathology, and complications. World J Pediatr 2016; 12 (2): 135-141. |
| [16] | Guinard-Samuel V, Bonnard A, De Lagausie P, Chomette P, Alberti C, El Ghoneimi A, et al. Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung disease. Modern Pathology 2009; 22: 1379–1384. |
| [17] | Keerthi CP, Prema NS. Comparison of Haematoxylin and Eosin Staining and Calretinin Immunohistochemistry in Clinically Suspected Hirschsprung Disease to Evaluate the Diagnostic Utility of Calretinin in Hirschsprung Disease. J. Evolution Med. Dent. Sci 2019; 8 (49): 3702-3706. |
| [18] | Rakhshani N, Araste M, Imanzade F, Panahi M et al. Hirschprung’s disease diagnosis: calretinin marker role in determining the presence or absense of ganglion cells. Iran J Pathol 2016; 11 (4): 409-415. |
| [19] | Hwang S, Kapur RS. Advances abd pitfalls in the diagnosis of Hirschprung’s disease. Surgical Pathology 2020: 13 p. |
| [20] | Tran VQ, Lam KT, Truong DQ, Dang MH et al. Diagnostic value of rectal suction using calretinin immunohistochemical staining in Hirschprung’s disease. Journal of Pediatric Surgery 2016; 5 p. |
| [21] | Setiadi JA, Dwihantoro A, Iskandar K et al. The utility of hematoxylin and eosin staining in patients with suspected Hirschprung’s disease. BMC Surg 2017; 17: 71. |
| [22] | Neuvonen MI, Kyrklund K, Lindahl HG, Koivusalo IA et al. A population-based follow-up of 146 consecutive patients after transanal mucosectomy for Hirschprung’s disease. Journal of Pediatric Surgery 2015. |
| [23] | Bedabrata M, Moumita S, Chhanda D, Madhumita M et al. Immunohistochemistry based comparative study in detection of Hirschsprung’s disease in infants in a Tertiary Care Center. J Lab Physicians 2017; 9 (2): 76-80. |
| [24] | Anwarul K, Akter M, Tasmiah AT, Hoque M, Tanvir KC, Imam MS et al. Epidemiological caracteristics of Hirschprung’s disease; Results of case series of fifty patients of from Bangladesh. Journal of Pediatric Surgery 2018; 53: 1955-1959. |
APA Style
Abdou Magib Gaye, Gabriel Nougnignon Comlan Deguenonvo, Ibou Thiam, Sophia Raafa, Marie Joseph Dieme-Ahouidi, et al. (2021). The Value of Calretinin in the Diagnosis of Hirschsprung's Disease in Dakar. American Journal of Pediatrics, 7(3), 178-181. https://doi.org/10.11648/j.ajp.20210703.27
ACS Style
Abdou Magib Gaye; Gabriel Nougnignon Comlan Deguenonvo; Ibou Thiam; Sophia Raafa; Marie Joseph Dieme-Ahouidi, et al. The Value of Calretinin in the Diagnosis of Hirschsprung's Disease in Dakar. Am. J. Pediatr. 2021, 7(3), 178-181. doi: 10.11648/j.ajp.20210703.27
AMA Style
Abdou Magib Gaye, Gabriel Nougnignon Comlan Deguenonvo, Ibou Thiam, Sophia Raafa, Marie Joseph Dieme-Ahouidi, et al. The Value of Calretinin in the Diagnosis of Hirschsprung's Disease in Dakar. Am J Pediatr. 2021;7(3):178-181. doi: 10.11648/j.ajp.20210703.27
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajp.20210703.27,
author = {Abdou Magib Gaye and Gabriel Nougnignon Comlan Deguenonvo and Ibou Thiam and Sophia Raafa and Marie Joseph Dieme-Ahouidi and Cherif Mouhamed Moustapha Dial},
title = {The Value of Calretinin in the Diagnosis of Hirschsprung's Disease in Dakar},
journal = {American Journal of Pediatrics},
volume = {7},
number = {3},
pages = {178-181},
doi = {10.11648/j.ajp.20210703.27},
url = {https://doi.org/10.11648/j.ajp.20210703.27},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20210703.27},
abstract = {Introduction: Hirschsprung's disease is a congenital anomaly characterised by a rarefaction or absence of ganglion cells associated with schwannian hyperplasia or hypertrophy involving the colon or a segment of the colon. Its diagnosis is based on clinical, radiological and histological evidence. Haematoxylin-eosin examination is used in cases of suspected Hirschsprung's disease. However, in some situations it is insufficient to confirm or refute the diagnosis. Immunohistochemical and histo-enzymatic techniques can be used to demonstrate aganglionosis. The aim of our study is to evaluate the interest of calretinin in the diagnosis of Hirschsprung's disease in Dakar. Materials and methods: This was a retrospective and descriptive study from 1 January 2018 to 31 August 2019. It was conducted at the pathology laboratory of Idrissa Pouye General Hospital where 51 paraffin blocks from suspected Hirschsprung's Disease cases were included. All blocks were immunohistochemically studied with anti-calretinin antibody. The diagnosis of Hirschsprung's disease on standard histological examination was based on the absence of lymph node cells in the submucosal and myenteric plexuses. Calretinin immunoreactivity was shown by nuclear and cytoplasmic labelling of ganglion cells and nerve nets. In Hirschsprung's disease, there is an absence of labelling of the nerve plexuses. Results: The majority of patients (73.5%) were aged 2 years or older with a mean age of 3.4 years. The sex ratio was 2. Biopsies constituted 56.86% of the specimens and surgical specimens 43.14%. Concordance between haematoxylin-eosin examination and calretinin immunohistochemistry was observed in 47 cases (92.15%) and discordance in 4 cases (7.15%). The sensitivity of calretinin was 93.75% and the specificity 89.47%. The kappa index was 0.92. The recto-sigmoid form was the most frequent topographic form observed in 83.3% of patients. Conclusion: Morphological examination with haematoxylin-eosin remains a good diagnostic method for Hirschsprung's disease. Calretinin immunohistochemistry is necessary in equivocal cases, in neonates and infants and in case of superficial biopsies.},
year = {2021}
}
TY - JOUR T1 - The Value of Calretinin in the Diagnosis of Hirschsprung's Disease in Dakar AU - Abdou Magib Gaye AU - Gabriel Nougnignon Comlan Deguenonvo AU - Ibou Thiam AU - Sophia Raafa AU - Marie Joseph Dieme-Ahouidi AU - Cherif Mouhamed Moustapha Dial Y1 - 2021/09/26 PY - 2021 N1 - https://doi.org/10.11648/j.ajp.20210703.27 DO - 10.11648/j.ajp.20210703.27 T2 - American Journal of Pediatrics JF - American Journal of Pediatrics JO - American Journal of Pediatrics SP - 178 EP - 181 PB - Science Publishing Group SN - 2472-0909 UR - https://doi.org/10.11648/j.ajp.20210703.27 AB - Introduction: Hirschsprung's disease is a congenital anomaly characterised by a rarefaction or absence of ganglion cells associated with schwannian hyperplasia or hypertrophy involving the colon or a segment of the colon. Its diagnosis is based on clinical, radiological and histological evidence. Haematoxylin-eosin examination is used in cases of suspected Hirschsprung's disease. However, in some situations it is insufficient to confirm or refute the diagnosis. Immunohistochemical and histo-enzymatic techniques can be used to demonstrate aganglionosis. The aim of our study is to evaluate the interest of calretinin in the diagnosis of Hirschsprung's disease in Dakar. Materials and methods: This was a retrospective and descriptive study from 1 January 2018 to 31 August 2019. It was conducted at the pathology laboratory of Idrissa Pouye General Hospital where 51 paraffin blocks from suspected Hirschsprung's Disease cases were included. All blocks were immunohistochemically studied with anti-calretinin antibody. The diagnosis of Hirschsprung's disease on standard histological examination was based on the absence of lymph node cells in the submucosal and myenteric plexuses. Calretinin immunoreactivity was shown by nuclear and cytoplasmic labelling of ganglion cells and nerve nets. In Hirschsprung's disease, there is an absence of labelling of the nerve plexuses. Results: The majority of patients (73.5%) were aged 2 years or older with a mean age of 3.4 years. The sex ratio was 2. Biopsies constituted 56.86% of the specimens and surgical specimens 43.14%. Concordance between haematoxylin-eosin examination and calretinin immunohistochemistry was observed in 47 cases (92.15%) and discordance in 4 cases (7.15%). The sensitivity of calretinin was 93.75% and the specificity 89.47%. The kappa index was 0.92. The recto-sigmoid form was the most frequent topographic form observed in 83.3% of patients. Conclusion: Morphological examination with haematoxylin-eosin remains a good diagnostic method for Hirschsprung's disease. Calretinin immunohistochemistry is necessary in equivocal cases, in neonates and infants and in case of superficial biopsies. VL - 7 IS - 3 ER -
Information
Email: